Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 177CNS 128Head & Neck 91Genitourinary 90Thoracic 83Sarcoma 69Breast 62Lymphoid 49Gynecologic 43Other hematologic neoplasm 31Dermatologic 27Tumor-Agnostic 14Other solid neoplasm 10Myeloid 7Plasma cell 6Other 5Endocrine 3NET 1Classical hematology 1

Conditions

Lymphoma, Follicular 1Anemia, Aplastic 1

Interventions

Cyclophosphamide 94fludarabine phosphate 87Busulfan 64Cyclosporine 57Epoetin Alfa 55Peripheral Blood Stem Cell Transplantation 54Mycophenolic Acid 54Whole-Body Irradiation 53fludarabine 45Antilymphocyte Serum 43Filgrastim 41Cytarabine 41Melphalan 40Tacrolimus 39Darbepoetin alfa 39Methotrexate 34Radiotherapy 33Cord Blood Stem Cell Transplantation 28Granulocyte Colony-Stimulating Factor 23apixaban 22Methylprednisolone 22Rivaroxaban 21Etoposide 21Thiotepa 17Dalteparin 17eltrombopag 16ferric carboxymaltose 14epoetin beta 14Daunorubicin 14Azacitidine 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Radiation × Classical hematology × Clear all
NCT00578903 2016-04-22

Allogeneic Stem Cell Transplant for Patients With Severe Aplastic Anemia

Baylor College of Medicine

Phase 2 Terminated
22 enrolled 11 charts
Classical hematologyLymphoid

Anemia, Aplastic, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡